IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. AZN
7. NVS
8. ROIV
9. ORCL
10. AAPL

Go back to IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
(NASDAQ: ICCM) Delayed: 2.21 --0 (-0%)
Previous Close $2.21    52 Week High $ 
Open $2.21    52 Week Low $ 
Day High $2.21    P/E N/A 
Day Low $2.21    EPS $ 
Volume 1,582